JAKARTA - PT Medela Potentia Tbk (MDLA) recorded solid financial performance throughout the 2025 fiscal year amid the dynamics of the national health industry. The company recorded double-digit net profit growth of 16 percent year-on-year of IDR 398.1 billion, supported by revenue growth of IDR 14.89 trillion.

President Director of PT Medela Potentia Tbk, Krestijanto Pandji, said that this achievement reflects the fundamental stability of the Company's business which is supported by the strengthening of the distribution system and operational optimization.

"The double-digit net profit growth is one of the positive indicators of the Company's performance throughout 2025. In the future, the Company will continue to focus on maintaining growth stability through strengthening logistics infrastructure and optimizing the business portfolio," he said, Thursday, April 2.

Throughout 2025, the Company strengthened its business portfolio through the addition of eight new principals consisting of two prescription drug principals, two consumer health principals, and four health care principals. This diversification is expected to enrich the distribution solutions offered while improving the Company's competitiveness in the health industry.

On the infrastructure side, the Company also continues to strengthen its distribution capabilities as part of its strategy to increase capacity and operational efficiency. In May 2025, the Company acquired National Distribution Center (NDC) 1 with an area of 10,000 square meters with a capacity of 13,525 pallets in the Jababeka Industrial Estate II, Cikarang, West Java, where the NDC 1 facility has been an integral part of the Company's distribution infrastructure for more than 10 years, and was previously used by the Company through a rental scheme from an affiliated company.

In addition, the Company also acquired land with an area of 2.7 hectares in the Jababeka I Industrial Estate which is planned for the development of NDC 2 PT Anugrah Argon Medica. This expansion will further strengthen the warehouse's capabilities while increasing the speed and quality of services to customers.

To expand the distribution reach in the Sumatra region, the construction of the warehouse and branch office of PT Anugrah Argon Medica in Medan is targeted to be completed by the end of 2026.

From the health equipment business line, the Company's subsidiary, PT Deca Metric Medica (DMM), has begun expanding the international market by exporting health equipment products to Cambodia and East Timor in August 2025.

Meanwhile, the Company's subsidiary in the field of health equipment marketing, PT Djembatan Dua, also continues to strengthen its own brand portfolio by launching three SKU products, to support total sales growth of 50 percent.

In the digital business line, the GoApotik platform recorded revenue growth of 32 percent with an increase in customer transactions of 24 percent compared to the previous year.

Apart from focusing on business growth, the Company also continues to implement the principles of Environmental, Social, and Governance (ESG) in the company's operations. Through the Argon Peduli program, various social activities have reached 23,488 beneficiaries throughout 2025.

The program is realized through various social initiatives such as free health check services, posyandu training, education scholarships, and stunting prevention programs.

The Company also collaborates with regulators in the Good Distribution of Medicines (CDOB) education as part of the Company's contribution to improving the quality of health services in Indonesia.

In the environmental aspect, the Company has implemented the use of electric motor-based operational vehicles to support energy efficiency and carbon emission reduction. By the end of 2025, the use of electric motors has been applied to 15 branches in 13 cities with a total of 106 units.

These various achievements reflect the Company's commitment to good corporate governance, encouraging innovation, and building a sustainable organization. Throughout 2025, the Company also received various awards for ESG practices, digital technology innovation, and human resource development.


The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)